Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Adolescent and Young Adult Oncology|November 11, 2022
Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction ChemotherapyBethany J Lockwood, Areej El-Jawahri, Alison R Walker, et al.
Oncotarget|March 9, 2018
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemiaBhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, et al.
Blood Advances|February 4, 2020
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemiaNitin Jain, Wendy Stock, Amer Zeidan, et al.
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
British Journal of Haematology|August 2, 2016
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemiaBhavana Bhatnagar, Ann-Kathrin Eisfeld, Deedra Nicolet, et al.
Investigational New Drugs|May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLJae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Leukemia|August 30, 2019
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21Bhavana Bhatnagar, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.
Pageof 6